These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 18029326
1. Antihypertensive efficacy of zofenopril plus hydrochlorothiazide fixed combination for treatment in metabolic syndrome. Malacco E, Omboni S. Adv Ther; 2007; 24(5):1006-15. PubMed ID: 18029326 [Abstract] [Full Text] [Related]
2. Fixed-dose combination of zofenopril plus hydrochlorothiazide vs. irbesartan plus hydrochlorothiazide in hypertensive patients with established metabolic syndrome uncontrolled by previous monotherapy. The ZAMES study (Zofenopril in Advanced MEtabolic Syndrome). Napoli C, Omboni S, Borghi C, ZAMES (Zofenopril in Advanced MEtabolic Syndrome) Study Group. J Hypertens; 2016 Nov; 34(11):2287-97. PubMed ID: 27653164 [Abstract] [Full Text] [Related]
3. Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies. Omboni S, Malacco E, Napoli C, Modesti PA, Manolis A, Parati G, Agabiti-Rosei E, Borghi C. Adv Ther; 2017 Apr; 34(4):784-798. PubMed ID: 28260186 [Abstract] [Full Text] [Related]
4. Zofenopril plus hydrochlorothiazide combination in the treatment of hypertension: an update. Borghi C, Omboni S. Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1055-65. PubMed ID: 25098297 [Abstract] [Full Text] [Related]
5. Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients. Agabiti-Rosei E, Manolis A, Zava D, Omboni S, ZODIAC Study Group. Adv Ther; 2014 Feb; 31(2):217-33. PubMed ID: 24415271 [Abstract] [Full Text] [Related]
6. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial. McGill JB, Reilly PA. Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284 [Abstract] [Full Text] [Related]
7. Antihypertensive effect of zofenopril plus hydrochlorothiazide versus zofenopril monotherapy in patients with essential hypertension according to their cardiovascular risk level: A post hoc analysis. Malacco E, Omboni S, Study Group. Curr Ther Res Clin Exp; 2008 Jun; 69(3):232-42. PubMed ID: 24692801 [Abstract] [Full Text] [Related]
8. Zofenopril plus hydrochlorothiazide: Combination therapy for the treatment of mild to moderate hypertension. Zanchetti A, Parati G, Malacco E. Drugs; 2006 Jun; 66(8):1107-15. PubMed ID: 16789795 [Abstract] [Full Text] [Related]
9. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials. Lacourcière Y, Neutel JM, Schumacher H. Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450 [Abstract] [Full Text] [Related]
10. Evaluation by 24-hour ambulatory blood pressure monitoring of efficacy of benazepril 20 mg plus hydrochlorothiazide 25 mg fixed combination as compared to captopril 50 mg [corrected] plus hydrochlorothiazide 25 mg fixed combination in treating mild to moderate hypertension: a double-blind, within-patient, placebo-controlled study. Fogari R, Zoppi A, Tettamanti F, Tettamanzi D, Lusardi P, Motolese M. J Cardiovasc Pharmacol; 1994 Nov; 24(5):687-93. PubMed ID: 7869731 [Abstract] [Full Text] [Related]
11. Comparative effects of zofenopril and hydrochlorothiazide on office and ambulatory blood pressures in mild to moderate essential hypertension. Lacourcière Y, Provencher P. Br J Clin Pharmacol; 1989 Mar; 27(3):371-6. PubMed ID: 2655685 [Abstract] [Full Text] [Related]
12. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D. Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [Abstract] [Full Text] [Related]
13. Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data. Borghi C, Cicero AF. Vasc Health Risk Manag; 2006 May; 2(4):341-9. PubMed ID: 17323587 [Abstract] [Full Text] [Related]
14. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM. Oigman W, Gomes MA, Pereira-Barretto AC, Póvoa R, Kohlmann O, Rocha JC, Nobre F. Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755 [Abstract] [Full Text] [Related]
15. A multicenter, randomized, double-blind, placebo-controlled, 8-week trial of the efficacy and tolerability of once-daily losartan 100 mg/hydrochlorothiazide 25 mg and losartan 50 mg/hydrochlorothiazide 12.5 mg in the treatment of moderate-to-severe essential hypertension. Gradman AH, Brady WE, Gazdick LP, Lyle P, Zeldin RK. Clin Ther; 2002 Jul; 24(7):1049-61. PubMed ID: 12182251 [Abstract] [Full Text] [Related]
16. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators. Guthrie R, Reggi DR, Plesher MM, Saini RK, Battikha JP. Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432 [Abstract] [Full Text] [Related]
17. Zofenopril or irbesartan plus hydrochlorothiazide in elderly patients with isolated systolic hypertension untreated or uncontrolled by previous treatment: a double-blind, randomized study. Modesti PA, Omboni S, Taddei S, Ghione S, Portaluppi F, Pozzilli P, Volpe M, Arca M, Calabrò P, Fulgheri PL, Bucci M, Berra S, Villani GQ, Vladoianu M, Popescu E, Velican VG, Pirvu O. J Hypertens; 2016 Mar; 34(3):576-87; discussion 587. PubMed ID: 26703917 [Abstract] [Full Text] [Related]
18. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study. Rosei EA, Rizzoni D, DIMS II (Delapril-Indapamide Multicenter Study II). J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793 [Abstract] [Full Text] [Related]
19. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension. Luccioni R, Sever PS, Di Perri T, Redon J, Laurandin I, Brault Y, Chastang C, Guez D. J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665 [Abstract] [Full Text] [Related]
20. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y. Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480 [Abstract] [Full Text] [Related] Page: [Next] [New Search]